Lifeward LFWD
NASDAQ LFWD
$7.35 +0.14 (+1.94%)
At close: Aug 20, 2026 · 12:59 PM UTC

Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026)

Lifeward (LFWD) posted Liabilities and Shareholders Equity of $33.4 million for Q1 2026, up 45.93% sequentially from $22.9 million in Q4 2025, and up 16.0% YoY from $28.8 million in Q1 2025.

Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Lifeward has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $33.4 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 16.0% year-over-year to $33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.3 million (down 31.9% YoY) and the FY2025 annual result came in at $22.9 million, down 24.89% from the prior year.
  • Liabilities and Shareholders Equity rose to $33.4 million in Q1 2026 per LFWD's latest filing, from $22.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $90.0 million in Q1 2022 and troughed at $22.9 million in Q4 2025.
  • A 5-year average of $53.9 million and a median of $55.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity rose 20.7% in 2022, then plunged 51.75% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $74.2 million in 2022, then retreated by 14.88% to $63.2 million in 2023, then plunged by 51.75% to $30.5 million in 2024, then declined by 24.89% to $22.9 million in 2025, then jumped by 45.93% to $33.4 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $33.4 million, $22.9 million, and $23.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Lifeward 20.56 Mn 11.11 Mn 2.71 Mn 35.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.42 Mn
Dec 31, 2025 22.90 Mn
Sep 30, 2025 23.17 Mn
Jun 30, 2025 26.78 Mn
Mar 31, 2025 28.81 Mn
Dec 31, 2024 30.49 Mn
Sep 30, 2024 45.77 Mn
Jun 30, 2024 50.98 Mn
Mar 31, 2024 55.22 Mn
Dec 31, 2023 63.19 Mn
Sep 30, 2023 69.22 Mn
Jun 30, 2023 65.81 Mn
Mar 31, 2023 68.98 Mn
Dec 31, 2022 74.24 Mn
Sep 30, 2022 80.77 Mn
Jun 30, 2022 85.80 Mn
Mar 31, 2022 90.00 Mn
Dec 31, 2021 94.75 Mn
Sep 30, 2021 98.72 Mn
Jun 30, 2021 71.71 Mn